-
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysisM Gaudino, I Hameed, ME Farkouh et al. -
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyCT January, LS Wann, H Calkins et al.
-
Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort studySchunk SJ, Zarbock A, Speer T et al.
-
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 YearsRA Buiten, EH Ploumen, P Zocca et al.
-
A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting StentsYL Han, B Xu, NeoVas Randomized Controlled Trial Investigators
-
Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary interventionAJ Kirtane, D Doshi, MB Leon et al.
-
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart AssociationLY Chen, MK Chung, LA Allen et al.
-
Routine Continuous Electrocardiographic Monitoring Following Percutaneous Coronary InterventionsMA Al-Hijji , R Gulati，M Singh et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
